In Silico Identification of Potential Inhibitors of  Substituted  Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2

 

Kavitha K1,2*, Srinivasan N1, Suresh R1, Mohan S2

1Department of Pharmacy, Faculty of Engineering and Technology, Annamalai University,

Annamalai Nagar, Tamil Nadu.

2Department of Pharmaceutical Chemistry, Karpagam College of Pharmacy,

Ottakalpandapam, Coimbatore, Tamil Nadu.

*Corresponding Author E-mail: kavithakrocks@gmail.com, kavitha@kcp.edu.in

 

ABSTRACT:

Quinazolin-4-one have been used to therapy a lot of afflictions of humans legendary works exemplify that it possesses various biological activities. In this research is proposed to discover the synthetic derived pyrazolone fused quinazolin-4-one and Spike protein of sars Co V II and to understand the Insilico molecular origin of its activity. Even though chemistry of quinazolin 4 one being as an recognized area , day by day newer more complex derivatives are still being discovered. Moreover, an assortment of prose quinazolinone exibits a strong lactam-lactim tautomeric interaction and further when the methyl group is present in the second position, the tautomeric effect is increased, including structural activity relationship studies of the ring system describe that  the position 2,6,8 are very much important for structure activity studies as well as inclusion of different heterocyclic moieties at position 3 could be enhances the different  types of biological activity as well as Antiviral activity. The newly designed and synthesized compounds  which is subjected to docking analysis as well as Computational study was performed using Auto dock 4, soon after admetSAR, also pkCSM Servers, were used to investigate drug likeness prophecy. This study suggested that the designed novel pyrazolone fused quinazolin-4-one derivatives (QPZ1-QPZ5) which are likely against the Sars COV-2 enzymes with  excellent binding affinity , further  obey’s Lipinski rule. Utilizing contemporary strategies, these novel synthetic molecule origins might establish a reliable medication or support potential lead identification. Identified potential compounds can be further taken for experimental studies, spectral analysis.

 

KEYWORDS: Spike protein, Sars COV 2, Quinazolin-4-one, Auto dock 4, ADMET, docking study.

 

 


INTRODUCTION: 

Numerous legislature of the Coronaviridae folks mingle in the human population along with characteristically stimulate reasonable respiratory infirmity1. In contrast, Respiratory Syndrome (SARS) caused through the novel corona virus SARS-CoV as well as bird flu caused via avian influenza (H5N1) virus have emerged as two vital infectious diseases amid pandemic latent. Both infections crossed the species obstacle to infect humans. .Quinazoline compounds stand for one of the majority active classes of molecules possessing a broad spectrum of biological activity2.

 

Corona viruses (CoVs) are single-stranded RNA viruses with enormous, enveloped along with positive wits which could infect both animals and also humans3. SARS was begin in Guangdong prefecture China at 2002 also its ultimate universal extended4. Chinese talisman bats proceed as SARS-CoV group hosts5. Intermediately hosts like civet cats also raccoon puppies, regularly marketed as foodstuff outlet in Chinese soaking markets, and enabled human diffusion6.

 

In this occasion, no innovative antiviral or accredited vaccination are accessible towards oppose SARS, even though established precautionary ladder, together with voyage bans even if patient remoteness ,in due course stopped up the SARS epidemic in 2002 and 2003. An early eruption pandemic was associated to seafood core, probably occupied into animal disclosure. In the end human-to-human illness emerged along with the along nowadays-called corona virus ailment 19 (COVID-19) dispersed exponentially at China. A distinctive corona virus, SARS-corona virus 2 (SARS-CoV-2), intimately related to SARS CoV was originate in clinics also be assumed toward survive the budding lung disease’s etiologic agent7. Infections are as well recognized at 24 non-china nations, interrelated through foreign trek whether sequencing correlations amongst SARS CoV-2 as well as SAR CoV. Translate keen on allied biological properties. Specifically occurrence opportunity exist presently uncertain8. Virus doorway into cells be synchronized through spike (S) Glycoprotein: Spike 1(S1) by spike (S) glycoprotein; spike 1 (S1) façade part helps the virus to be associated in the direction of cellular proteins. Cellular proteases hew the S Protein in the S1/S2 also S20 positions towards permit viral element access. The viral capside is next merged among the cellular membrane subunit S2-guided course9. It was reputable so as to angiotensin-converting enzyme 2 (ACE2) mediates SARS CoV entry as well as that serine protease TMPRSS2 which is accountable for S Protein cleavage10. Investigation of receptor requisite motif (RBM) sequences inside the receptor binding province reveal that its answerable for binding towards ACE2 also that residues encompass be conserved with SARS Co V and also SARS-Co V 2, representing to facilitate binding to ACE2 might be alike even as the similar residues be absent in other corona viruses11,12. Some of the human ACE2 antibodies avoided SARS-CoV,SARS-CoV-2 infections13. Furthermore proteases are sole of the crucial also best studied proteins in corona viruses14. Its most important for the giving out poly proteins which are translated among viral RNA15. Inhibition of this viral Protease willpower outcome interested in the blocking of viral interested reproduction. SARS-and MERS-CoVs genomes comprise two open impression frames ORF1a and ORF1b translated towards two particular viral polyproteins pp1a and pp1a by host ribosome. ORF1a encodes two cysteine proteases, a papain-like protease (PLpro) and a 3CL-like protease (3CLPro). Whereas PLpro cuts the initial three cleavage sites of its polyproteins, 3CLpro is liable for cleavage of the lasting 11 locations resulting in release of a total of 16 non-structural proteins (nsp) in both SARS-and MERS-CoVs.the homodimeric form of 3CLpros is active in the presence of substrates. The crystal structures of both 3CLpros showed so as to each monomer is composed of three structural domains: domains I and II form a chymotrypsin-like structural design with a catalytic cysteine and are connected to a third C-Terminal domain via a long loop16 In the proteolytic site, all 3CL pros prefer glutamine at P1 position and leucine, basic residues, small hydrophobic residues at P2, P3 and P4 Positions, correspondingly. At P10 and P20 positions, small residues are required nevertheless; P30 Position shows no strong preference. Ever since the auto cleavage process is central for viral propagation, 3CLpro is a good drug target for anti-corona viral infection17.

 

In these conditions, the expansion of inhibitors towards the SRAS Co-V 2 main Protease gains significance into the drug innovation progression against COVID-19. Lately, the crystal structure of inhibitor barrier SARS-CoV 2 main protease18,19. Presently, the Insilico study includes develop into a preliminary also crucial part of the drug innovative process, as well as which influence the whole course of drug design and progress. This is typically given that in silico offer momentous cost, effort and time reductions as well as more green another compared to synthetic chemistry. Lastly the mainly imperative reflection with in silico move towards be with the purpose of its spare investigational animals. Moreover, for generating particular inhibitors, awareness of the differences between infective organisms as well their relevant host’s biochemical pathways, metabolism and also macromolecular structure, metabolism, in addition to detailed description of target proteins and macromolecules being a primary consequence20.

 

MATERIALS AND METHODS:

Computational resources Molecular docking simulations were used to predict the correct binding conformation of the ligand in the enzyme-binding pocket. The scoring function (dock score) comprised steric and electrostatic components of binding parameterized universal force fields. This utility allowed screening a set of compounds for lead optimization. Molecular graphics laboratory (MGL) tools and Auto Dock vina PyRx virtual screening tool was downloaded from www.scripps.edu, ChemSketch was downloaded from www.acdlabs.com, biovia Discovery studio visualizer was downloaded from https://www.3dsbiovia.com/biovia-discovery. The Mol file of Ligand to PDB format translation was carried out by using Chem 3D Pro 8.0 and protein to PDB format translation was carried out carried out by Molecular operating environment (MOE) were used. Molecular docking carried out by using a dell Personal Computer (PC) with a intelcore processor and Windows 7 operating system. Docking studies were carried out using the Ligand docking methology (GRIP) batch docking method implemented in auto dock 4 software packages.

 

Molecular Docking Studies:

Grounding of Macromolecules:

Main Protease and spike Protein domain complexed with ACE2 (PDP ID: 6M2N, 6VW1) of the crystal l structures be retrieved in the RCSB PDB (Protein data Bank) catalog. The graphical client boundary series “Auto dock utensils be used to set up, scuttle and also scrutinize the docking study results. Since, ligands exist not peptides, Gasteiger indict be structured followed with non polar hydrogen’ was combined .Auto dock desires for pre designed grid maps, sole for ultimate atom appearance in attendance into the ligand mortal docked keen on the same time as it provisions the potential energy arise. The grid requirements enclose the location of magnitude that is active site in the macromolecule.

 

Ground work of Ligands, Investigation of Drug Likeness:

The structure forms of the subsequent the 3D structure crystal forms of the subsequent energetic molecules of Quinazolin-4-one were designed zone of ChemDraw zone database, drug-likeness of ligands texture are calculated for the preferred active compounds active by pkCSM software.

 

Legalization of target protein- ligands structures:

Auto dock 4.0 Tactic be validated with the relevant co-crystallized ligands of target proteins to make sure the effective selection process. Auto dock 4.0 represents realistic RMSD attain and precise requisite with target receptor. In this research, for SARS CoV II Protein (PDB ID: 6M2N, 6VW1), the energetic location were determined in the Biovia Drug discovery studio visualizer.

 

Docking:

Docking was performed using PyRx auto dock vina. The results were quantified in terms of free binding energy. The highest binding energy values corresponding to the RMSD value of zero were considered as the binding affinity value of the Ligands. The [post dock analysis was made using biovia discovery studio visualizer. The prepared crystal structures of ligand and active site of various enzymes such as crystal structure of [PDB ID: 6M2N] were subjected to Auto dock Vina for measuring the binding energies. The docking grid box was set at approx. above 90 90 90 and genetic algorithm (GA) with default settings was employed for the studies. In the search parameter, number of runs and the other settings were left as default. The results of docking calculations seen in the output were in word format21.

 

The position and orientation of Ligands in protein receptor and the interaction with amino acids that bound to the ligand were analyzed and visualized with Auto Dock tools. During the docking process the top ten conformations were simulated for each of the compound after the minimization of the energy. The binding energy of each ligand against 3CL PRO macromolecule was predicted using auto dock vina, which is one of the most commonly used docking software. in the docking procedure ,eight binding pose were obtained, and the binding bose with the highest binding energy corresponding to the RMSD value of zero was considered as the binding affinity of the ligand. The amino acid residues interacting with the selected quinazolinone derivatives and all molecules showed hydrogen bond interactions, many having Vander walls attraction with different amino acid residues in the binding site. In general, all the libraries of quinazolinones were found to have more binding affinity than the chloroquine. This is due to an increased number of hydrogen bond, vanderwalls attraction with the amino acids of the binding site. The most active compound was which showed hydrogen bond interactions over the enzyme although pialkyl interactions, also pi-sigma interactions were analyzed.

 

Drug likeness, Bio activity prediction, and ADMET properties:

The molecular structure were drawn by using advanced chemistry department (ACD)/ChemSketch version 12.0 as well as (SMILES) Simplified molecular –input line entry system notation data be created and fed keen on these software’s to calculate the parameters. In silico studies which have helped to resolve the activity of the compound while within the body while as well acting as a vital tool for the drug innovative process also for the lead optimization. The molecular descriptors, drug likeness features of 2 substituted pyrazolone fused quinazolin-4-one derivatives done by using the molinspiration tool server (http://www.molinspiration.com) which given the outcome of Lipinski’s rule of five (RO5). ADMET of the ligands is pharmacokinetic property computation to facilitate, be necessary toward exist examined to launch their utility inside the body. The ADMET legacy of the ligands was deliberate, making use of admetSAR (http://lmmd.ecust.edu.cn/admetsar2/22.

 

RESULTS AND DISCUSSION:

Designing:

The sequence of molecules were designed depends on the outcome present in the literature associated towards the active binding site of SARS Co-V 2.the structural features for efficient interaction with the receptor as well as various parameters that have been explored in this study. The prominent features known from the literature were H- Bonding and π-stacking interactions are crucial, essential for the binding of inhibitors within the active position of SARS CoV 2. The amino acid residues interacting within the newly designed quinazolin-4-one derivatives and also except few all the compounds exibits hydrogen bond interactions, many having Vander walls attraction among different amino acid residues in the binding site. In general, all the selected quinazolinones were found to have excellent binding affinity because of an increased number of hydrogen bond, vanderwalls attraction with the amino acids of the binding location. The most active moiety was which exhibited hydrogen bond interactions over the enzyme although pialkyl interactions, also pi-sigma interactions were analysis (QPZ1-QPZ5) listed in Table:2

 

Molecular docking studies:

In order to categorize the potential aspirant for managing COVID-19, molecular docking done as well executed newly designed synthetic molecules from the derivatives of quinazolin-4-one on the binding pocket of enzyme COVID-19 (PDB ID:6M2N,6VW1). Assortment of lirature which was undoubtedly says that entry of virus within the host cell by the assistance of ACE2 receptors-Protein binds in a straight line to the Angiotensin Converting Enzyme 2 (ACE2) receptor of the human host cell face so as to enable the virus access and replication. In this study selected PDP ID: 6VW1 where spike protein its complexed with ACE2 towards explore the binding affinity of quinazolin-4-one derivatives with the complex23. all these designed compounds (QPZ1-QPZ5) were docked in opposition to the target protein COVID 19 as well as ranked depends on their docked value. Generally, Compounds exhibiting docked score of 7.0 or even less or more than that are thought concerning the better agent for restraint of the COVID-19.A complete assessment could be done and enlisted in the table no: 2 and the table exemplify the list of active compounds acquired later on docking studies. Those active as well designed molecules possess excellent docked value of more than 7.0 kcal/mol. Among 5(QPZ1-QPZ5) compounds were selected depends on the binding affinity with 6M2N AND 6VW1 (fig: 1-3).from designed proposed molecules, Quinazolin-4-one derivatives QPZ5 having the best docked value (-9.5kcal/mol) with SARS-CoV2 Main Proteases (6M2N) and also QPZ2 possess the best docked value of (-8.6kcal/mol) with SARS CoV2 Spike Protein (6VW1).

 

Molecular Interaction Studies:

Drug likeliness, Bio activity and ADMET evaluation:

In drug development, Absorption, distribution, metabolism, and elimination (ADME) properties play a vital role in the victory or stoppage of aspirant molecules .reduced properties could limit the exposure of the molecules to the target enzyme. Toxicity is one more especially imperative factor which regularly overshadows the ADME actions. Lipinski’s rule is functional in assess the bioavailability of the orally administered drugs. The newly designed molecules were studied for the drug likeness of molecular properties as well as bioactivity by molinspiration. further the prediction of ADMET Properties was used admetSAR databases. All the newly designed compounds in order to veber’s rule which they have rotatable bonds less than 10 as well TPSA not more than 140.and also its indicate that designed compounds may have good oral absorption24. Table 1 represents that all the new quinazolin-4-one of drug likeness properties. Human Intestinal Absorption value should be in the 0.9 and further which indicates good intestinal absorption. AMES toxicity test evaluation employed to find the whether a drug is mutagenic or not so as all the designed compounds (QPZ1-QPZ5) which is influenced negative values, that is they are non-mutagenic as well as non carcinogenic and also designed compounds have exhibited lower oral acute toxicity LD50 which is a dose that causes of 50% test population .and also was found to be somewhat higher range, could be measured to be safe as well as range of LD50 listed in table-3. The bioactivity value of the designed quinazolin-4-one derivatives as G-Protein coupled receptor(GPCR) ligand, nuclear receptor ligand, ion channel modulator, a kinase inhibitor, protease inhibitor, also enzyme inhibitor were analyzed as well represented in table-4.A Moiety exhibited bioactivity value of more than 0.00 is most expected to reveal significant biological activity. Bioactivity scores be additional towards 0.0 for enzyme inhibition when compared to other mechanisms25. Compounds had bioactivity value more than 0.00 for enzyme inhibition, therefore which could be they can be measured to possess significant biological activity by the respective mechanism. The newly designed compounds given bioactivity score between -0.21and -0.14. These results validate the basis at the back of designing series as SARS CoV2 inhibitor.

 

 

Quinazoli-4-one

 

               Mpro (6M2N)                              Spike Protein (6VW1)

Figure 1: General Structure of newly Designed Compounds and 3D crystal structure of the Macromolecules of COVID-19

 

Table1. Physicochemical effects of the energetic molecules among the rules of drug-likeness

Ligands

MW

Logp

Alogp

HBA

HBD

TPSA

Nrb

No of violation

QPZ1

457.94

4.12

 4.33

4

3

77.69

5

0

QPZ2

468.49

3.37

 3.58

6

3

123.52

6

0

 

QPZ3

453.52

3.47

 3.68

5

3

86.93

6

 

QPZ4

466.57

3.53

 3.74

5

3

80.93

6

0

QPZ5

441.49

3.60

 3.81

4

3

77.69

5

0


 

Table2. Interactions of COVID-19 Mpro (6M2N) and Spike Protein (6VW1) amino acid residues with Quinazolin-4-one moieties on receptor sites

Code

Binding affinity Kcal/mol

 Vander Waals

H.bond

Pi –alkyl

Pi-sigma

6M2N

6VW1

6M2N

6VW1

 

6M2N

6VW1

 

6M2N

6VW1

 

6M2N

6VW1

 

QPZ1

-9.0

-8.3

THR D:24,26,45,SER D:46,123, LEU D:27,141, ASN D:119,GLY D:143,THR D:26

GLU A:536,B:435,GLN A:531,ASN A:586,B:432,GLU A:527,536,B:435,PRO B:538,HIS B: 540

ASN D:142

HIS A:535

 ----

LEU A:539,PRO B:590

THR D:25,TYR D:118(pi-pi stacked

LYS A:534,B:541(Pi cation)

QPZ2

-9.2

-8.6

CYS D:44,SER D:46,123,ARG B:298,LEU D:141,ASN D:142,GLY D:143,MED T:49,THR D:45

PRO B:135,612,THR B:158,613,ASN A:134,159,GLU A:160

ASN D:119

 ----

 ----

LEU B:162,TRP B:163

THR D:25,TYR D:118(pi-pi stacked)

TYR B:255

)QPZ3

-9.0

-8.3

ILE A:106,200,THR A:111,292,VAL A:202,SER A:158,ASP A:153,295,PHE A:8,PRO A:108,GLY A:109,GLU A:240

PRO B:135,612,TYR B:158,613,ASN B:134,159,GLU B:160.

PHE A:294,GLN A:110

 ----

ILE A:249,ASN A:151(pi-pi T shaped)

LEU B:162, TRP B:163(pi-pi T shaped)

HIS A:246(pi cation)

TYR B:255

QPZ4

-8.8

-8.3

PRO A:108,293,VAL A:104,202,ILE A:106,200,THR A:111,292,SER A:158,ASN A:151,ASP A:295,PHE A:8,GLY A:109,GLU A:240

GLU A:527,536,B:430,435,ASN B:432,HIS B:540,PRO B:538,ILE B:436

GLN A:110

HIS A:535,GLY A:537,GLN A:531

ILE A:249

LEU A:539,PRO B:590

HIS A:546(pi cation)

LYS A:534,B:541(PI cation)

QPZ5

-9.5

-8.2

LEU D:27,141,VAL D:42,THR D:26,45,HIS D:41,GLY D:143,ARG D:298,SER D:123

LYS A:534,GLU B:430,435,527,536,HIS A:535,B:540,ASN A:586,B:432,PRO B:538,590

CYS D:44,SER D:46,ASV D:119,142

 GLN A:531,GLY A:537

TYR D:118,D:3WL401

LEU A:539

THR D:25

LYS A:541(pi cation)

 

Table3. ADMET possessions of newly designed Quinazolin-4-one derivatives

Ligands

HIA

BBB

AMES Toxicity

Carcinogenicity

LD 50 in rat(mol/kg)

QPZ1

0.9045

0.9802

Non -toxic

Non-carcinogenic

2.066

QPZ2

0.9592

0.9762

Non-toxic

Non-carcinogenic

2.156

QPZ3

0.9013

0.9771

Non-toxic

Non-carcinogenic

2.552

QPZ4

0.8834

0.9803

Non-toxic

Non-carcinogenic

2.056

QPZ5

0.8920

0.9802

Non-toxic

Non-carcinogenic

2.085

 

 

Table: 4.Bioactivity score of proposed molecule of Quinazolin-4-one derivatives

C.Code

GPCR Ligand

Ion channel modulator

Kinase inhibitor

Nuclear receptor ligand

Protease inhibitor

Enzyme inhibitor

QPZ1

0.12

0.34

0.47

0.16

0.12

0.18

QPZ2

0.21

0.39

0.54

0.20

0.18

0.21

QPZ3

0.14

0.39

0.47

0.15

0.13

0.18

QPZ4

0.10

0.36

0.41

0.12

0.10

0.14

QPZ5

0.11

0.35

0.43

0.13

0.11

0.16

HIA: human intestinal absorption; BBB: Blood-Brain Barrier; LD50: Lethal Dose, 50%

 

QPZ5 (6M2N)                                    QPZ2 (6VW1)                                QPZ5 (6VW1)                             QPZ2 (6M2N )

 

QPZ5 (6M2N)                             QPZ2 (6VW1)                           QPZ5 (6VW1)                                    QPZ2 (6M2N)

 Figure 2: Best Binding pose and 2D Structure of the molecular intention with Main Protease and Spike Protein (6M2N, 6VW1)

 


From above study the docking poses was produced according towards docking parameters and their resultant binding pockets. These investigations be supposed helpful for considerate the binding interactions over the targeted protein. Molecular docking studies of selected quinazolin-4-one derivatives be take away and in addition docked binding affinity values of selected derivatives resulting within the value of -8.2kcal/mol and -9.5kcal/mol which listed at table -2 and Fig.2 . Each and every one of the proposed molecules be set up towards effectively clutch behind the SARS CoV 2 Mpro and Spike protein as a outcome of entirely the capable site into intend protein. The result of docking exploration be exhibited to every one of the docked moieties include lower energy value (high binding energy value). Moreover the various interaction value of designed molecules (QPZ1-QPZ5) which showed at table-2. Exemplify the most excellent low binding energy (high binding energy values) for the docked compounds. Along with 5 Ligands so as to be docked by the enzyme Mpro and spike protein the substituted NO2 and F group with novel Quinazolinone of ligand (QPZ2 and QPZ5) showed the majority effective in the midst of high binding score of -8.6kcal/mol and -9.5kcal/mol The substituted ligand Cl, OCH3 group exibits best docked score of (QPZ1–QPZ3 ) 8.3kcal/mol and 9.0kcal/mol and Substituted ligand N(CH3)2 (QPZ4) molecule exibits score of - kcal/mol while the ligand 30E -6.0 kcal/mol with 97.97 value of TPSA based 808kcal/mol and -8.3kcal/mol. Among all the selected ligands no violation exibits drug likeness properties. Further among entire selected quinazolinone molecules left over the molecules bare admirable blood brain barrier (B.B.B), human intestinal absorption (HIA), with no carcinogenicity and AMES negative as well as good bioavailability. The docked ligand configuration display Hydrogen bond and electrostatic interaction, Pi alkyl and Pi sigma interactions present in table-2.These communications showing that Ligands bind profound in the core of energetic site where the quinazoli-4-one ligand binds against action of SARS-CoV2 Enzymes.

 

CONCLUSION:

In present research, include and selected molecules of quinazoli-4-one derivatives followed by explore Sars CoV2 Mpro and Spike Protein Enzymes binding interaction by docking study using PDB ID: 6M2Nand 6VW1 . A number of proposed quinazolinone synthetic molecules in that some of moieties which produce with a excellent range of binding score were confirmed. Molecular docking studies data given that the most potent with the high docking score -9.5kcal/mol and 8.6kcal/mol as well as ADMET belongings. Based on the docking scores and physiochemical properties of the compound were selected and additional studies furthermore this study suggests in the purpose of the selected Compounds build known the imperative action against main protease and spike protein enzyme which may be useful to develop better inhibitory Sars CoV 2 of quinazolin-4-one derivatives and also sets necessitate for further series of molecules will be synthesized and tested for SARS CoV 2 activity.

 

ACKNOWLEDGEMENT:

The authors are very much gratified to Annamalai University, Annamalai Nagar, Chidambaram, Tamilnadu, India, for the supervision for successful academic philosophy research.

 

The authors are also thankful to the Principal and Management of Karpagam College of Pharmacy, Coimbatore, for providing necessary infrastructure.

 

REFERENCES:

1.      Corman V, Lienau J, Witzenrath M.Coronaviruses as the cause of respiratory infections. Der Internist.Corona viruses as the cause of respiratory infections. Der Internist. 2019:60(11):1136-1145. https://doi.org/10.1007/s00108-019-00671-5

2.      Desai NC, Amit Dodiya, Niraj Shihory. Synthesis and antimicrobial activity of novel quinazolinone-thiazolidine-quinoline compounds. Journal of Saudi Chemical Society. 2013: 17:259-267. https://doi.org/10.1016%2Fj.jscs.2011.04.001

3.      Lai MM, Cavanagh D.The molecular biology of corona viruses. Adv virus Res. 1997: 48: 1-100. https://doi.org/10.1016/S0065-3527(08)60286-9

4.      De Wit, E., Van Doremalen, N., Falzarano D, Munster VJ.SARS and MERS: recent insights into emerging corona viruses. Nat Rev Microbial. 2016: 14: 523-534. https://doi.org/10.1038/nrmicro.2016.81

5.      Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS like corona Viruses Science. 2005: 310: 676-679. https://doi.org/10.1126/science.1118391

6.      Guan Y, Zheng B.J, Guan He YQ, Liu X.L, Cheung C.L, Luo S.W, et al. Isolation and characterization of viruses related to the SARS corona virus from animals in southern china. Science (New York, N.Y). 2003: 302(5643): 276-278. https://www.ncbi.nlm.nih.gov/books/NBK92471

7.      Chan J.F-W, Yuan S, Kok K-H, To, K.K.-W, Chu H, Yang J, Xing F, ‘et al’. A familial cluster of pneumonia associated with the 2019 novel corona virus indicating person-to-person transmission: A study of a family cluster. Thelancet. 2020: 395(10223): 514-523.https://doi.org/10.1016/S0140-6736(20)30184-7,and https://doi.org/10.1016/ S0140-6736(20)30185-9

8.      Munster VJ, Koopmans M, Van Doremalen, Van Riel D, and de Wit E. A novel corona virus emerging in china-key questions for impact assessment. New England Journal of Medicine. 2020: 382(8): 692-694. https://doi.org/10.1056/nejmp2000929

9.      Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, ‘et al’.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor cell.2020:181(2):271-280. https://doi.org/10.1016/j.cell.2020.02.052

10.   Hassan A, Paray BA, Hussian A, Qadir FA, Attar Aziz FM, ‘et al’. A review on the cleavage priming of the spike protein on corona virus by angiotensin-converting enzyme-2 and furin.Journal of Biomolecular structure and Dynamics. 2020:1-13. https://doi.org/10.1080/07391102.2020.1754293

11.   GeX Y, Li JL, Yang XL,Chmura AA,Zhu G, Epstein JH, ‘et al’. Isolation and characterization of a bat SARS-like corona virus that virus that uses the ACE2 receptor.Nature. 2013:503(7477):535-538. https://doi.org/10.1038/nature12711

12.   Menachery VD, Dinnon KH, Yount BL, McAnarney ,ET., Gralinski, LE, Hale A,et al.Trypsin treatment unlocks barrier for zoonotic bat corona virus infection. Journal of Virology. 2019: 94(5): e01774-19. https://doi.org/10.1128%2FJVI.01774-19

13.   Boopathi S, Poma AB, and Kolandaivel SP. Novel 2019 corona virus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. 2020: 1-14. https://doi.org/10.1080/07391102.2020.1758788

14.   Khan SA, Zia K, Ashraf S, Uddin R, and Ul-Haq Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics. 2020: 1-13. https://doi.org/10.1080/07391102.2020.1751298

15.   Hilgenfeld R. From SARS to MERS: Crystallographic studies on corona viral proteases enable antiviral drug design. The FEBS Journal, 2014: 281(18): 4085-4096. https://doi.org/10.1111/febs.12936

16.   Neddle D, Lountos, GT., Waugh, DS. Structures of the Middle East respiratory syndrome corona virus 3C like protease reveal insights into substrate specificity. Acta Crrystallography. 2015: D71:1102-11. https://doi.org/10.1107/s1399004715003521

17.   ChunckCP, ChowHF, WanDC, WongKB. Profiling of substrate specificities of 3C like Proteases from group 1,2a,2b, and 3 corona viruses. PLoS one. 2011: 6: e27228. https://doi.org/10.1080/14756366.2019.1690480

18.   Khan RJ, Jha RK, Amera G, Jain M, Singh E, Pathak A, Singh RP, ‘et al. Targeting SARS-CoV-2. A systematic drug repurposing approach to identify promising inhibitors against 3C-like Proteinase and 2’-O-Ribosemethyltransferase.Journal of Biomolecular Structure and Dynamics. 2020: 1-40. https://doi.org/10.1080/07391102.2020.1753577

19.   ZhangL,LinD,SunX,CurthU,DrostenC,Sauerhering L, Becker S, et al. Crystal structure of SARS-CoV-2 main Protease provides a basis for design of improved a-ketoamide inhibitors. Science. 2020: 368(6489): 409-412. https://doi.org/10.1126/science.abb3405

20.   Datta AK, Datta R, Sen B. Anti parasitic chemo therapy: tinkering with the purine salvage pathway. Adv Exp Med Biol. 2008: 625: 116-132. https://doi.org/10.1007/978-0-387-77570-8_10

21.   Rajasekhar KK, Nizamuddin abdrrahman Shemsu Surur ND, Yennus Tadesse Mekonnen. Synthesis, characterization, anti tubercular and anti bacterial activity and molecular docking of 2, 3-di substituted quinazolinone derivative. Research and Reports in Medicinal Chemistry. 2016: 6:15-26. https://doi.org/10.2147/RRMC.S91474

22.   Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, and Tang Y. Admet SAR: A comprehensive source and free tool for assessment of chemical ADMET properties. ACS Publications. https://doi.org/10.1021/ci300367a

23.   Sinha SK, Shakya, Prasad SK, Singh S, Gurav NS, Prasad RS and Gurav SS. An in-silico valuation of different saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics. 2020:1-13. https://doi.org/10.1080/07391102.2020.1762741

24.   Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. Journal of Med Chem. 2002: 45: 2615-2623. http://dx.doi.org/10.1021/jm020017n

25.   Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as sum of fragment-based contributions its application to the prediction of drug transport properties Med Chem. 2000: 43:3714-3717. https://doi.org/10.1021/jm000942e

 

 

 

 

Received on 30.11.2020            Modified on 13.06.2021

Accepted on 02.11.2021           © RJPT All right reserved

Research J. Pharm. and Tech 2023; 16(5):2470-2476.

DOI: 10.52711/0974-360X.2023.00407